Safety and efficacy of B-domain truncated recombinant factor VIII in previously treated patients with hemophilia A: Comparison of data between total population and Japanese subject population | Zendy

AI Assistant Blog Pricing

Safety and efficacy of B-domain truncated recombinant factor VIII in previously treated patients with hemophilia A: Comparison of data between total population and Japanese subject population

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.